RC-14 - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
75631747
Word Mark
RC-14
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2001-01-02
Filing Date
1999-02-02
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
JENKINS JR, CHARLES L
Statements
Goods and Services
Lactobacillus for use in foods, medical compositions, pharmaceutical preparations and dietary products; probiotics for the restoration of urogenital health, the treatment of urongenitial infections and the maintenance of healthy urogential flora; bacterial cultures containing lactobacillus for use as a substance which provides a nutritional, functional or medical health benefit; medicinal preparations for the restoration of urogenital health; the treatment of urogenital infections and the maintenance of healthy urogenital flora
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
1999-03-20
Primary Code
005
Correspondences
Name
STEPHEN D. MURPHY
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 1999-07-15 | ASSIGNED TO EXAMINER |
| 1999-07-29 | NON-FINAL ACTION MAILED |
| 2000-02-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2000-05-12 | NON-FINAL ACTION MAILED |
| 2001-01-02 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
